Skincare giant Beiersdorf is doubling down on artificial intelligence (AI).
The German-based company, which owns the brands Nivea, Eucerin and La Prairie, has partnered with the AI business Insilico Medicine – which develops end-to-end drug discovery pipelines – to carry out computer-simulated skin research. The duo will explore "novel, safe bioactive ingredients", with Beiersdorf aiming to use the findings as a basis for eventual skincare product development.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
